These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 27769862

  • 1. miR-543 is up-regulated in gefitinib-resistant non-small cell lung cancer and promotes cell proliferation and invasion via phosphatase and tensin homolog.
    Bi M, Chen W, Yu H, Wang J, Ding F, Tang DJ, Tang C.
    Biochem Biophys Res Commun; 2016 Nov 18; 480(3):369-374. PubMed ID: 27769862
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. miR-1271 promotes non-small-cell lung cancer cell proliferation and invasion via targeting HOXA5.
    Wang Y, Xu L, Jiang L.
    Biochem Biophys Res Commun; 2015 Mar 13; 458(3):714-719. PubMed ID: 25686496
    [Abstract] [Full Text] [Related]

  • 4. miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.
    Lei L, Huang Y, Gong W.
    Oncol Rep; 2013 Dec 13; 30(6):2897-902. PubMed ID: 24084898
    [Abstract] [Full Text] [Related]

  • 5. Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancer.
    Shen H, Zhu F, Liu J, Xu T, Pei D, Wang R, Qian Y, Li Q, Wang L, Shi Z, Zheng J, Chen Q, Jiang B, Shu Y.
    PLoS One; 2014 Dec 13; 9(7):e103305. PubMed ID: 25058005
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.
    Xie X, Liu HT, Mei J, Ding FB, Xiao HB, Hu FQ, Hu R, Wang MS.
    Int J Clin Exp Pathol; 2015 Dec 13; 8(4):3827-34. PubMed ID: 26097565
    [Abstract] [Full Text] [Related]

  • 9. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
    Ma G, Zhu J, Liu F, Yang Y.
    DNA Cell Biol; 2019 Feb 13; 38(2):176-183. PubMed ID: 30601026
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN.
    Wang H, Guan X, Tu Y, Zheng S, Long J, Li S, Qi C, Xie X, Zhang H, Zhang Y.
    J Exp Clin Cancer Res; 2015 Jun 11; 34(1):59. PubMed ID: 26063204
    [Abstract] [Full Text] [Related]

  • 13. The miR-875-5p inhibits SATB2 to promote the invasion of lung cancer cells.
    Wang J, Lu Y, Ding H, Gu T, Gong C, Sun J, Zhang Z, Zhao Y, Ma C.
    Gene; 2018 Feb 20; 644():13-19. PubMed ID: 29196257
    [Abstract] [Full Text] [Related]

  • 14. Loss of PTEN expression by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations.
    Yamamoto C, Basaki Y, Kawahara A, Nakashima K, Kage M, Izumi H, Kohno K, Uramoto H, Yasumoto K, Kuwano M, Ono M.
    Cancer Res; 2010 Nov 01; 70(21):8715-25. PubMed ID: 20959484
    [Abstract] [Full Text] [Related]

  • 15. HOXA4-regulated miR-138 suppresses proliferation and gefitinib resistance in non-small cell lung cancer.
    Tang X, Jiang J, Zhu J, He N, Tan J.
    Mol Genet Genomics; 2019 Feb 01; 294(1):85-93. PubMed ID: 30196354
    [Abstract] [Full Text] [Related]

  • 16. Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3.
    Yue J, Lv D, Wang C, Li L, Zhao Q, Chen H, Xu L.
    Oncogene; 2018 Aug 01; 37(31):4300-4312. PubMed ID: 29717264
    [Abstract] [Full Text] [Related]

  • 17. MiR-130a overcomes gefitinib resistance by targeting met in non-small cell lung cancer cell lines.
    Zhou YM, Liu J, Sun W.
    Asian Pac J Cancer Prev; 2014 Aug 01; 15(3):1391-6. PubMed ID: 24606471
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.